pharmacytimes.com

The Use of CMR in Patients With Recurrent Pericarditis Initiating Rilonacept

News

Article

April 2, 2025

Author(s):

Conference|ACC Scientific Session - American College of Cardiology Scientific Session

Listen

Key Takeaways

CMR imaging is crucial for diagnosing and monitoring recurrent pericarditis, especially in complex cases.

The RESONANCE registry aims to improve understanding and management of recurrent pericarditis and assess rilonacept's real-world effectiveness.

SHOW MORE

The registry data showed that cardiac magnetic resonance (CMR) was obtained in more clinically complex patients with recurrent pericarditis.

Related Videos

Cardiovascular Risks of BTK Inhibitors: What Pharmacists Need to KnowPersonalized Prevention: Identifying At-Risk Patients With Image-Based ScreeningSotatercept Demonstrates Its Potential in the Phase 3 ZENITH TrialFINEARTS-HF Analysis: How Liver Biomarkers Influence Heart Failure RiskSemaglutide and Cardiovascular Risk Reduction: What the Latest Data Tell UsNew Data Highlights Abelacimab’s Safety Advantage in Atrial FibrillationExploring the Vascular Benefits of Semaglutide in Peripheral Artery DiseaseAPhA 2025: A Pharmacist’s Guide to Culturally Competent and Inclusive CareSharita Howe, PharmD, on Leadership, Pharmacy, and Innovation: ‘Pharmacists Are Like Superheroes, We Can Do Anything’

Read full news in source page